Vertex Appoints Jonathan Biller as Chief Legal Officer

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jonathan Biller has been appointed Chief Legal Officer, effective September 19, 2022. Mr. Biller will report directly to Vertex’s Chief Executive Officer and President, Reshma Kewalramani, M.D., and join the company’s Executive Committee. In this role, Mr. Biller will oversee all of Vertex’s global legal and … [Read more…]

NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development

TOLEDO, Ohio & TEL AVIV, Israel–(BUSINESS WIRE)–#CRO—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for treatment of carotid artery disease and prevention of stroke, announced today that they have entered into a strategic outsourcing partnership to accelerate … [Read more…]

Cutera Announces Over 1,000 AviClear™ Acne Treatments Performed

AviClear becomes the fastest adopted device in Cutera’s history BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announces that over 1,000 AviClear laser treatments have been performed in the United States. AviClear is the first and only energy-based device to be FDA-cleared for the … [Read more…]

LLR Partners Announces Significant Growth Investment in VPL

PHILADELPHIA & WESTERVILLE, Ohio–(BUSINESS WIRE)–#LLR—LLR Partners today announced a significant growth investment in Vantage Point Logistics (“VPL”), a supply chain management software provider that helps healthcare organizations improve resiliency and visibility of clinical supply chains. The capital will be used to support VPL’s continued product innovation and organic growth along with the exploration of strategic … [Read more…]

Longhorn Vaccines and Diagnostics Appoints Zoe Silver as Senior Vice President of Genomics & Diagnostics

Silver has decades of experience in shepherding products, including molecular diagnostics, to commercialization within the medical and consumer industries BETHESDA, Md. & GAITHERSBURG, Md.–(BUSINESS WIRE)–Longhorn Vaccines and Diagnostics LLC, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, announced today that Zoe Silver has joined the company as … [Read more…]

Exscientia Welcomes Caroline Rowland as Chief People Officer

OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today announced that Caroline Rowland has joined Exscientia as Chief People Officer. In this newly created role, she will lead Exscientia’s People (human resources) and Places functions and build on the Company’s talent, training and employee experience strategies. Caroline reports to CEO and Founder, Andrew Hopkins, DPhil. “Exscientia was … [Read more…]

Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development

LAUSANNE, Switzerland & TEL AVIV, Israel–(BUSINESS WIRE)–#biomarker—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the … [Read more…]

LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced the application for certification of the ALLY™ Adaptive Cataract Treatment System (“ALLY” or the “ALLY System”) in the European Union. “Following the FDA clearance of ALLY … [Read more…]

Orca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies

– New state-of-the art manufacturing facility is designed to enable the reliable production of Orca Bio’s investigational cell therapies from late-stage clinical development through potential commercialization – – The 100,000-square-foot facility is located in Metro Air Park, Sacramento – MENLO PARK, Calif.–(BUSINESS WIRE)–Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment … [Read more…]

Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules for Precision Phosphorylation to Modulate and Repair Disease-Driving Proteins

– Phosphorylation-inducing chimeric small molecules (PHICS) are a new class of bifunctional medicines that direct and repair aberrant and dysfunctional proteins – PHICS enable precise phosphorylation, an important post-translational modification that controls protein function, including activation, stabilization, trafficking, inactivation, and degradation – Led by a strong foundational management team of respected industry veterans with deep … [Read more…]